{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical#webpage",
"url": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical",
"name": "Globalization of Clinical Trials: Giving More Patients Access to Cancer Therapies at the Point of Clinical Decision Making",
"description": "This Fortrea info sheet highlights digital oncology research approaches focused on supporting data-driven clinical development and innovation across modern oncology programs. The publication discusses digital biomarkers, precision oncology research, digital health innovation, and oncology-focused data integration strategies designed to improve clinical development insights and support evolving cancer research activities. The publication also highlights emerging approaches related to digitally enabled oncology research, biomarker-driven clinical development, oncology data analysis, and technology-supported precision medicine strategies within cancer clinical studies. Fortrea supports sponsors through digitally enabled oncology research strategies designed to strengthen operational efficiency, improve oncology insights, and support innovation across cancer therapeutic development programs. By integrating digital oncology research with precision medicine approaches and data-driven clinical development strategies, Fortrea supports more advanced oncology research capabilities and improved clinical development outcomes."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Globalization of Clinical Trials: Giving More Patients Access to Cancer Therapies at the Point of Clinical Decision Making",
"item": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical#webpage"
},
"headline": "Advancing Digital Oncology Research Through Data-Driven Clinical Development | Fortrea Info Sheet",
"description": "This Fortrea info sheet highlights digital oncology research approaches focused on supporting data-driven clinical development and innovation across modern oncology programs. The publication discusses digital biomarkers, precision oncology research, digital health innovation, and oncology-focused data integration strategies designed to improve clinical development insights and support evolving cancer research activities. The publication also highlights emerging approaches related to digitally enabled oncology research, biomarker-driven clinical development, oncology data analysis, and technology-supported precision medicine strategies within cancer clinical studies. Fortrea supports sponsors through digitally enabled oncology research strategies designed to strengthen operational efficiency, improve oncology insights, and support innovation across cancer therapeutic development programs. By integrating digital oncology research with precision medicine approaches and data-driven clinical development strategies, Fortrea supports more advanced oncology research capabilities and improved clinical development outcomes.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-12",
"dateModified": "2025-07-12",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/clinical-trials-patient-access-cancer-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}